Editing
Non-RCC Renal Malignancies
(section)
Jump to navigation
Jump to search
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
== Sarcomas of the Kidney == === Background === *'''Renal sarcoma is less common but more lethal than sarcoma of any other genitourinary site''' === Epidemiology === *Represent 1-2% of all malignant renal tumors in adults * Peak incidence in the 5th decade of life === Pathology === * '''Leiomyosarcoma is the most common histologic subtype of renal sarcoma''' === Natural History === *High-grade sarcomas often metastasize, with the lungs being a primary site of spread, and prognosis is poor; many patients die of disease progression in a matter of months. **Sarcomas are derived from mesenchymal components and are thus free of many of the natural barriers to dissemination that confine other tumor types. *Low-grade sarcomas tend to pursue a more indolent course === Diagnosis and Evaluation === *'''Signs and Symptoms (similar to those seen with large, rapidly growing RCCs)''' *#'''Palpable mass''' *#'''Abdominal or flank pain''' *#'''Hematuria''' *Differentiation of renal sarcoma from sarcomatoid RCC is often difficult on the basis of clinical presentation, radiographic findings, and, in some cases, pathologic analysis === Management === *'''Primarily a surgical disease''' **'''Wide excision is the goal with intraoperative monitoring of margin status''' ***The initial resection is the key event because this is the best chance for a long-term cure. ***This often mandates RN along with en bloc excision of adjacent organs. *'''Chemotherapy''' **'''Has demonstrated some activity against metastatic sarcomas''' **'''Response rates are disappointing''' *'''Combined radiation therapy and chemotherapy''' **'''Has proved effective in an adjuvant setting for the management of sarcomas of the extremity, has not provided much benefit for renal or retroperitoneal sarcomas'''. *A multimodal approach is often pursued if performance status allows, given the poor prognosis. === Prognosis === * '''Most important prognostic factors for sarcomas (2)''' *#'''Margin status''' *#'''Tumor grade'''
Summary:
Please note that all contributions to UrologySchool.com may be edited, altered, or removed by other contributors. If you do not want your writing to be edited mercilessly, then do not submit it here.
You are also promising us that you wrote this yourself, or copied it from a public domain or similar free resource (see
UrologySchool.com:Copyrights
for details).
Do not submit copyrighted work without permission!
Cancel
Editing help
(opens in new window)
Navigation menu
Personal tools
Not logged in
Talk
Contributions
Create account
Log in
Namespaces
Page
Discussion
English
Views
Read
Edit
Edit source
View history
More
Search
Navigation
Main page
Clinical Tools
Guidelines
Chapters
Landmark Studies
Videos
Contribute
For Patients & Families
MediaWiki
Recent changes
Random page
Help about MediaWiki
Tools
What links here
Related changes
Special pages
Page information